Updated on 2021/10/26

写真a

 
SHINDO Yuichiro
 
Organization
Nagoya University Hospital Respiratory Medicine Assistant Professor
Graduate School
Graduate School of Medicine
Title
Assistant Professor
Contact information
メールアドレス

Degree 1

  1. M.D., Ph.D. (Medicine) ( 2011.3   Nagoya University ) 

Research Interests 7

  1. COVID-19

  2. 免疫療法

  3. リスク因子

  4. 薬剤耐性

  5. 抗菌治療

  6. 肺炎

  7. 呼吸器感染症

Research Areas 1

  1. Others / Others  / Respiratory Medicine

Research History 3

  1. Nagoya University   Department of Respiratory Medicine, Nagoya University Hospital   Assistant Professor

    2016.4

  2. Nagoya University   Institute for Advanced Research,   Designated assistant professor

    2011.4 - 2016.3

      More details

    Country:Japan

  3. Nagoya University   Graduate School of Medicine   Designated assistant professor

    2011.4 - 2016.3

      More details

    Country:Japan

Education 2

  1. Nagoya University   Graduate School, Division of Medical Sciences   Department of Respiratory Medicine

    2007.4 - 2011.3

      More details

    Country: Japan

  2. Miyazaki Medical College   Faculty of Medicine

    1995.4 - 2001.3

      More details

    Country: Japan

Professional Memberships 12

  1. The Japanese Society of Internal Medicine

  2. The Japanese Respiratory Society

  3. The Japanese Association for Infectious Diseases

  4. Japanese Society of Chemotherapy

  5. The Japanese Society for Tuberculosis

  6. The Japanese Society of Intensive Care Medicine

  7. The Japanese Society for Respiratory Care and Rehabilitation

  8. The Japanese Society of Allergology

  9. American Thoracic Society

  10. American College of Chest Physician

    2013.10

  11. European Respiratory Society

  12. Japanese Section of the American College of Chest Physicians

▼display all

Committee Memberships 8

  1. 日本呼吸器学会   「ストップ肺炎」推進委員会 委員  

    2020.11   

  2. 日本呼吸器学会   COVID-19診療エキスパートオピニオン ワーキンググループ 委員  

    2020.11   

  3. 日本呼吸器学会   肺炎診療ガイドライン作成委員会 委員  

    2020.11   

  4. 日本感染症学会   気道感染症の抗菌薬適正使用委員会委員  

    2018.9 - 2021.2   

      More details

    Committee type:Academic society

  5. 日本結核・非結核性抗酸菌症学会   結核診療ガイドライン統括委員会 委員  

    2018.6   

  6. 日本結核・非結核性抗酸菌症学会   代議員  

    2018.3   

  7. 日本呼吸器学会   「ストップ肺炎」推進委員会 委員  

    2012.2 - 2013.1   

  8. 日本呼吸器学会   医療・介護関連肺炎診療ガイドライン作成委員会 委員  

    2009.11 - 2011.8   

▼display all

Awards 5

  1. 平成26年度日本呼吸器学会 学会奨励賞

    2015.4   日本呼吸器学会  

     More details

    Country:Japan

  2. The 2009 Research Award of Japanese Section of the American College of Chest Physicians

    2010.10   Japanese Section of the American College of Chest Physicians  

     More details

    Country:Japan

  3. MTPI ATS Abstract Scholarship Travel Award

    2014.5   American Thoracic Society   Mortality Risks In Patients With Pneumonia Who Received Appropriate Initial Antibiotics

    Shindo Y.

     More details

    Award type:Award from international society, conference, symposium, etc.  Country:United States

  4. Young Investigator Award to the ATS (American Thoracic Society) 2009

    2009.2   Japanese Respiratory Society  

     More details

    Country:Japan

  5. 第12回(2012年度)内藤記念若手研究者海外派遣助成金(秋季)

    2012.9   公益財団法人 内藤記念科学振興財団  

     More details

    Country:Japan

 

Papers 78

  1. Risk factors for 30-day mortality in patients with pneumonia who receive appropriate initial antibiotics: an observational cohort study Reviewed

    Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Goto Y, Fukui Y, Iwaki M, Okumura J, Yamaguchi I, Yagi T, Tanikawa Y, Sugino Y, Shindoh J, Ogasawara T, Nomura F, Saka H, Yamamoto M, Taniguchi H, Suzuki R, Saito H, Kawamura T, and Hasegawa Y

    Lancet Infect Dis   Vol. 15   page: 1055 - 1065   2015.7

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/S1473-3099(15)00151-6

    PubMed

  2. Risk Factors for Drug-Resistant Pathogens in Community-Acquired and Healthcare-Associated Pneumonia Reviewed

    Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, Goto Y, Fukui Y, Iwaki M, Okumura J, Yamaguchi I, Yagi T, Tanikawa Y, Sugino Y, Shindoh J, Ogasawara T, Nomura F, Saka H, Yamamoto M, Taniguchi H, Suzuki R, Saito H, Kawamura T, and Hasegawa Y, on behalf of the Central Japan Lung Study Group.

    Am J Respir Crit Care Med     page: [Epub ahead of print]   2013

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

  3. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia Reviewed

    Shindo Y*, Fuchs AG, Davis CG, Eitas T, Unsinger J, Burnham CA, Green JM., Morre M, Bochicchio GV, and Hotchkiss RS

    J Leukoc Biol   Vol. 101   page: 531-542   2017

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

  4. Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure

    Shindo Yuichiro, Kondoh Yasuhiro, Kada Akiko, Doi Yohei, Tomii Keisuke, Mukae Hiroshi, Murata Naohiko, Imai Ryosuke, Okamoto Masaki, Yamano Yasuhiko, Miyazaki Yasunari, Shinoda Masahiro, Aso Hiromichi, Izumi Shinyu, Ishii Haruyuki, Ito Ryota, Saito Akiko M., Saito Toshiki I, Hasegawa Yoshinori

    INFECTIOUS DISEASES AND THERAPY     2021.8

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese  

    DOI: 10.1007/s40121-021-00512-9

    Web of Science

    PubMed

  5. Anti-Programed Cell Death Ligand 1 Peptide Improves Survival in Sepsis Reviewed

    Shindo Y, McDonough JS, Chang KC, Ramachandra M, Sasikumar PG, and Hotchkiss RS

    J Surg Res   Vol. 2017   page: 33-39   2017

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  6. Regional differences in antibiotic-resistant pathogens in patients with pneumonia: Implications for clinicians Invited Reviewed

    Shindo Y, Hasegawa Y

    Respirology   Vol. 22   page: 1536-1546   2017

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    PubMed

  7. Interleukin 7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression Reviewed

    Shindo Y, Unsinger J, Burnham C, Green J, and Hotchkiss R

    Shock   Vol. 43   page: 334-343   2015

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1097/SHK.0000000000000317

  8. International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline: A Critical Appraisal by a Global Expert Panel.

    Pletz MW, Blasi F, Chalmers JD, Dela Cruz CS, Feldman C, Luna CM, Ramirez JA, Shindo Y, Stolz D, Torres A, Webb B, Welte T, Wunderink R, Aliberti S

    Chest   Vol. 158 ( 5 ) page: 1912 - 1918   2020.11

     More details

  9. Combination of aspirin plus macrolides in patients with severe community-acquired pneumonia: a hypothesis-generating study.

    Falcone M, Russo A, Shindo Y, Farcomeni A, Pieralli F, Cangemi R, Liu J, Xia J, Okumura J, Sano M, Jones C, Vannucchi V, Mancone M, Micek S, Xu F, Violi F, Kollef M

    Antimicrobial agents and chemotherapy   Vol. 63 ( 2 )   2019.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1128/AAC.01556-18

    Web of Science

    PubMed

  10. Validation of the prediction rules identifying drug-resistant pathogens in community-onset pneumonia

    Kobayashi Daisuke, Shindo Yuichiro, Ito Ryota, Iwaki Mai, Okumura Junya, Sakakibara Toshihiro, Yamaguchi Ikuo, Yagi Tetsuya, Ogasawara Tomohiko, Sugino Yasuteru, Taniguchi Hiroyuki, Saito Hiroshi, Saka Hideo, Kawamura Takashi, Hasegawa Yoshinori

    INFECTION AND DRUG RESISTANCE   Vol. 11   page: 1703 - 1713   2018

     More details

    Authorship:Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.2147/IDR.S165669

    Web of Science

    PubMed

  11. Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy Reviewed

    Okumura J, Shindo Y, Takahashi K, Sano M, Sugino Y, Yagi T, Taniguchi H, Saka H, Matsui S, Hasegawa Y.

    Respirology   Vol. 23 ( 5 ) page: 526 - 534   2018.5

     More details

    Authorship:Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/resp.13232

    Web of Science

    PubMed

  12. T cells from Patients with Candida Sepsis Display a Suppressive Immunophenotype Reviewed

    Spec A, Shindo Y, Burnham CD, Wilson S, Ablordeppey E, Beiter ER, Chang K, Drewry AM, Hotchkiss RS.

    Crit Care   Vol. 20 ( 1 ) page: 15   2016.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s13054-016-1182-z

    PubMed

  13. Multidrug-resistant pathogens in patients with pneumonia coming from the community Invited Reviewed

    Sibila O, Rodrigo-Troyano A, Shindo Y, Aliberti S, and Restrepo MI

    Curr Opin Pulm Med   Vol. 22   page: 219-226   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  14. Endothelial Adhesion Molecules and Multiple Organ Failure in Patients With Severe Sepsis Reviewed

    Amalakuhan B, Habib S, Mangat M, Reyes LF, Rodriguez AH, Hinojosa CA, Soni NJ, Gilley RP, Bustamante CA, Anzueto A, Levine SM, Peters JI, Aliberti S, Sibila O, Chalmers JD, Torres A, Waterer GW, Martin-Loeches I, Bordon J, Blanquer J, Sanz F, Marcos PJ, Rello J, Ramirez J, Solé-Violán J, Luna CM, Feldman C, Witzenrath M, Wunderink RG, Stolz D, Wiemken TL, Shindo Y, De La Cruz C, Orihuela1 CJ, and Restrepo MI

    Cytokine   Vol. 88   page: 267-273   2016

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  15. Molecular Epidemiological Characteristics of Klebsiella pneumoniae Associated with Bacteremia among Patients with Pneumonia Reviewed

    Ito R, Shindo Y, Kobayashi D, Ando M, Jin W, Wachino J, Yamada K, Kimura K, Yagi T, Hasegawa Y, and Arakawa Y

    J Clin Microbiol   Vol. 53   page: 879-886   2015

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1128/JCM.03067-14

  16. Pneumonia pathogen characterization is an independent determinant of hospital readmission Reviewed

    Andruska A, Micek S, Shindo Y, Hampton N, Colona B, McCormick S, and Kollef M

    Chest   Vol. 148   page: 103-111   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1378/chest.14-2129

  17. Prospective analysis of efficacy and safety of an individualized-midazolam-dosing protocol for sedation during prolonged bronchoscopy Reviewed

    Ogawa T, Imaizumi K, Hashimoto I, Shindo Y, Imai N, Uozu S, Shimokata T, Ito S, Hashimoto N, Sato M, Kondo M, and Hasegawa Y

    Respir Investig   Vol. 52   page: 153-159   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  18. Clinical practice guidelines for nursing- and healthcare-associated pneumonia (NHCAP)

    Kohno S, Imamura Y, Shindo Y, Seki M, Ishida T, Teramoto S, Kadota J, Tomono K, Watanabe A.

    Respir Invest   Vol. 51   page: 103-126   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  19. Emerging Problems Regarding Severity Assessment and Treatment Strategies for Patients with Pneumonia: Controversies Surrounding the HCAP Concept Invited Reviewed

    Shindo Y, Hasegawa Y

    Intern Emerg Med   Vol. 6 ( 5 ) page: 389-391   2011.9

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s11739-011-0623-6

  20. Healthcare-Associated Pneumonia: Diagnostic Criteria and Distinction from Community-Acquired Pneumonia Reviewed

    Falcone M, Venditti M, Shindo Y, Kollef MH

    Int J Infect Dis   Vol. 15   page: e545-550   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  21. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital Reviewed

    Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Hashimoto N, Imaizumi K, Sato T, Hasegawa Y

    Chest   Vol. 135   page: 633-640   2009

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  22. Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia Reviewed

    Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Imaizumi K, Hasegawa Y

    Respirology   Vol. 13   page: 731–735   2008

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  23. Clinical Characteristics and Genotypes of Pneumocystis Pneumonia in non-HIV Patients Reviewed

    Matsumura Y, Shindo Y, Iinuma Y, Yamamoto M, Shirano M, Matsushima A, Nagao M, Ito Y, Takakura S, Hasegawa Y, Ichiyama S

    BMC Infect Dis   Vol. 11   page: 76   2011

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  24. Implication of clinical pathway care for community-acquired pneumonia in a community hospital: early switch from an intravenous beta-lactam plus a macrolide to an oral respiratory fluoroquinolone Reviewed

    Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Imaizumi K, Hasegawa Y

    Intern Med   Vol. 47   page: 1865-1874   2008

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  25. The Mystery of Futility of Appropriate Antibiotics for Co-Infection in COVID-19.

    Kasugai D, Jingushi N, Omote N, Shindo Y, Goto Y

    American journal of respiratory and critical care medicine     2021.9

     More details

    Language:English  

    DOI: 10.1164/rccm.202107-1656LE

    PubMed

  26. Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report.

    Dela Cruz CS, Evans SE, Restrepo MI, Dean N, Torres A, Amara-Elori I, Awasthi S, Caler E, Cao B, Chalmers JD, Chastre J, Cohen TS, Cohen AH, Crothers K, Di YP, Egan ME, Feldman C, Gautam S, Halstead ES, Herold S, Jones BE, Luna C, Niederman MS, Mendez R, Menendez R, Mizgerd JP, Nusrat R, Ramirez J, Shindo Y, Waterer G, Yeligar SM, Wunderink RG

    Annals of the American Thoracic Society   Vol. 18 ( 7 ) page: 1087 - 1097   2021.7

     More details

    Language:English  

    DOI: 10.1513/AnnalsATS.202102-209ST

    PubMed

  27. 市中肺炎のマネージメント Invited

    進藤有一郎

    呼吸器内科   Vol. 39 ( 6 ) page: 465 - 470   2021.6

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese   Publishing type:Research paper (scientific journal)  

  28. Usefulness of Respiratory Mechanics and Laboratory Parameter Trends as Markers of Early Treatment Success in Mechanically Ventilated Severe Coronavirus Disease: A Single-Center Pilot Study.

    Kasugai D, Ozaki M, Nishida K, Hiraiwa H, Jingushi N, Numaguchi A, Omote N, Shindo Y, Goto Y

    Journal of clinical medicine   Vol. 10 ( 11 )   2021.6

     More details

    Language:English  

    DOI: 10.3390/jcm10112513

    PubMed

  29. 教えて!○○科のお医者さん 呼吸器内科 Invited

    進藤有一郎

    ニュートン別冊     page: 74 - 77   2021.6

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese  

  30. Surgical Strategy and Optimal Timing of Tracheostomy in Patients with COVID-19: Early Experiences in Japan Invited Reviewed

    Nishio N, Hiramatsu M, Goto Y, Shindo Y, Yamamoto T, Jingushi N, Wakahara K, Sone M.

    Auris Nasus Larynx   Vol. 48 ( 3 ) page: 518 - 524   2021.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.anl.2020.11.004

    DOI: 10.1016/j.anl.2020.11.004

    PubMed

  31. Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study.

    Ikeda S, Misumi T, Izumi S, Sakamoto K, Nishimura N, Ro S, Fukunaga K, Okamori S, Tachikawa N, Miyata N, Shinkai M, Shinoda M, Miyazaki Y, Iijima Y, Izumo T, Inomata M, Okamoto M, Yamaguchi T, Iwabuchi K, Masuda M, Takoi H, Oyamada Y, Fujitani S, Mineshita M, Ishii H, Nakagawa A, Yamaguchi N, Hibino M, Tsushima K, Nagai T, Ishikawa S, Ishikawa N, Kondoh Y, Yamazaki Y, Gocho K, Nishizawa T, Tsuzuku A, Yagi K, Shindo Y, Takeda Y, Yamanaka T, Ogura T

    Scientific reports   Vol. 11 ( 1 ) page: 10727   2021.5

     More details

    Language:English  

    DOI: 10.1038/s41598-021-90246-y

    PubMed

  32. Failure of non-invasive respiratory support after 6 hours from initiation is associated with ICU mortality

    Nishikimi Mitsuaki, Nishida Kazuki, Shindo Yuichiro, Shoaib Muhammad, Kasugai Daisuke, Yasuda Yuma, Higashi Michiko, Numaguchi Atsushi, Yamamoto Takanori, Matsui Shigeyuki, Matsuda Naoyuki

    PLOS ONE   Vol. 16 ( 4 ) page: e0251030   2021.4

     More details

  33. Never Let a Good Crisis Go to Waste. Reviewed International coauthorship

    Metersky M, Aliberti S, Feldman C, Luna C, Shindo Y, Sotgiu G, Waterer G.

    Chest   Vol. 159 ( 3 ) page: 917 - 919   2021.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.chest.2020.10.018

    DOI: 10.1016/j.chest.2020.10.018

    PubMed

  34. 特集 新型コロナウイルス感染症IX オール愛知での診療体制を目指して. Invited

    進藤有一郎.

    名古屋医報   Vol. 1473   page: 2 - 3   2021.2

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese  

  35. 呼吸器薬物療法―現場ではこう使いこなす― 抗菌薬:βラクタム薬、カルバペネム、モノバクタム、キノロン、アミノ配糖体、マクロライド、抗MRSA薬. Invited

    進藤有一郎.

    呼吸器ジャーナル   Vol. 69   page: 44 - 51   2021

     More details

    Language:Japanese  

  36. Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies.

    Ramirez JA, Musher DM, Evans SE, Dela Cruz C, Crothers KA, Hage CA, Aliberti S, Anzueto A, Arancibia F, Arnold F, Azoulay E, Blasi F, Bordon J, Burdette S, Cao B, Cavallazzi R, Chalmers J, Charles P, Chastre J, Claessens YE, Dean N, Duval X, Fartoukh M, Feldman C, File T, Froes F, Furmanek S, Gnoni M, Lopardo G, Luna C, Maruyama T, Menendez R, Metersky M, Mildvan D, Mortensen E, Niederman MS, Pletz M, Rello J, Restrepo MI, Shindo Y, Torres A, Waterer G, Webb B, Welte T, Witzenrath M, Wunderink R

    Chest   Vol. 158 ( 5 ) page: 1896 - 1911   2020.11

     More details

  37. Anesthetic and surgical management of tracheostomy in a patient with COVID-19.

    Hiramatsu M, Nishio N, Ozaki M, Shindo Y, Suzuki K, Yamamoto T, Fujimoto Y, Sone M

    Auris, nasus, larynx   Vol. 47 ( 3 ) page: 472 - 476   2020.6

     More details

  38. Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study

    Miyazaki Taiga, Yanagihara Katsunori, Kakeya Hiroshi, Izumikawa Koichi, Mukae Hiroshi, Shindo Yuichiro, Yamamoto Yoshihiro, Tateda Kazuhiro, Tomono Kazunori, Ishida Tadashi, Hasegawa Yoshinori, Niki Yoshihito, Watanabe Akira, Soma Kazui, Kohno Shigeru

    JOURNAL OF INFECTION AND CHEMOTHERAPY   Vol. 26 ( 2 ) page: 242 - 251   2020.2

     More details

  39. ER・ICUでの薬の使い方・考え方―エキスパートが実践する秘訣(コツ):市中肺炎/誤嚥性肺炎. Invited Reviewed

    進藤有一郎.

    救急・集中治療   Vol. 32   page: 672 - 677   2020

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese  

  40. 呼吸器内科に必要な抗微生物薬の知識:アミノグリコシド系. Invited

    進藤有一郎.

    呼吸器内科   Vol. 37   page: 51 - 57   2020

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese  

  41. 院内肺炎・人工呼吸器関連肺炎の治療―国内外のガイドラインと実臨床での考えかた. Invited

    進藤有一郎.

    Medicina   Vol. 57   page: 66 - 71   2020

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese  

  42. The Diversity of Lipopolysaccharide (O) and Capsular Polysaccharide (K) Antigens of Invasive <i>Klebsiella pneumoniae</i> in a Multi-Country Collection.

    Choi M, Hegerle N, Nkeze J, Sen S, Jamindar S, Nasrin S, Sen S, Permala-Booth J, Sinclair J, Tapia MD, Johnson JK, Mamadou S, Thaden JT, Fowler VG Jr, Aguilar A, Terán E, Decre D, Morel F, Krogfelt KA, Brauner A, Protonotariou E, Christaki E, Shindo Y, Lin YT, Kwa AL, Shakoor S, Singh-Moodley A, Perovic O, Jacobs J, Lunguya O, Simon R, Cross AS, Tennant SM

    Frontiers in microbiology   Vol. 11   page: 1249   2020

     More details

  43. BK virus-associated viruria and viremia in a patient with lymphangioleiomyomatosis after lung re-transplantation: A case report and review of the literature on BK virus infection post-lung transplantation

    Okumura Junya, Nakahara Yoshio, Nakaguro Masato, Shindo Yuichiro, Hase Tetsunari, Wakahara Keiko, Hashimoto Naozumi, Hasegawa Yoshinori

    JOURNAL OF INFECTION AND CHEMOTHERAPY   Vol. 25 ( 10 ) page: 820 - 824   2019.10

     More details

  44. 院内肺炎、医療・介護関連肺炎の抗菌薬治療. Invited

    進藤有一郎、長谷川好規.

    Medical Practice   Vol. 35   page: 617 - 622   2018

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese  

  45. 病棟管理栄養士のための臨床検査ファーストガイド―疾患別検査値の意味と読み方のポイント 肺炎. Invited

    進藤有一郎、田中文彦.

    臨床栄養   Vol. 133   page: 589 - 592   2018

     More details

    Authorship:Lead author   Language:Japanese  

  46. Regional differences in antibiotic-resistant pathogens in patients with pneumonia: Implications for clinicians

    Shindo Yuichiro, Hasegawa Yoshinori

    RESPIROLOGY   Vol. 22 ( 8 ) page: 1536 - 1546   2017.11

  47. Anti-PD-L1 peptide improves survival in sepsis

    Shindo Yuichiro, McDonough Jacquelyn S., Chang Katherine C., Ramachandra Murali, Sasikumar Pottayil G., Hotchkiss Richard S.

    JOURNAL OF SURGICAL RESEARCH   Vol. 208   page: 33 - 39   2017.2

     More details

  48. Interleukin 7 immunotherapy improves host immunity and survival in a two-hit model of Pseudomonas aeruginosa pneumonia.

    Shindo Y, Fuchs AG, Davis CG, Eitas T, Unsinger J, Burnham CD, Green JM, Morre M, Bochicchio GV, Hotchkiss RS

    Journal of leukocyte biology   Vol. 101 ( 2 ) page: 543 - 554   2017.2

     More details

  49. 肺炎における薬剤耐性菌のリスクと抗菌治療. Invited

    進藤有一郎、長谷川好規.

    分子呼吸器病   Vol. 21   page: 52 - 55   2017

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese  

  50. 肺炎の重症度と薬剤耐性菌のリスク因子の評価. Invited

    進藤有一郎、長谷川好規.

    化学療法の領域     2016

     More details

    Authorship:Lead author, Corresponding author   Language:Japanese  

  51. Reply: HCAP Not Busy Being Born Is Busy Dying Reviewed

    Shindo Y and Hasegawa Y

    Am J Respir Crit Care Med   Vol. 189   page: 366-367   2014

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  52. Reply: Isolation of drug-resistant pathogens does not always require antibiotics of broad spectrum in pneumonia Reviewed

    Shindo Y and Hasegawa Y

    Am J Respir Crit Care Med   Vol. 189   page: 757-758   2014

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  53. Endobronchial ultrasound transbronchial needle aspiration in older people Reviewed

    Okachi S, Imai N, Imaizumi K, Hase T, Shindo Y, Sakamoto K, Aso H, Wakahara K, Hashimoto I, Ito S, Hashimoto N, Sato M, Kondo M, and Hasegawa Y.

    Geriatr Gerontol Int     2013.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1111/ggi.12043

  54. 医療・介護関連肺炎の定義と病態 Invited

    進藤有一郎、長谷川好規

    月刊ナーシング   Vol. 32   page: 10-13   2012

     More details

    Authorship:Lead author   Language:Japanese  

  55. NHCAPの原因菌と耐性菌の危険因子 Invited

    進藤有一郎、長谷川好規

    治療   Vol. 94   page: 39-42   2012

     More details

    Authorship:Lead author   Language:Japanese  

  56. 新たな肺炎治療の考え方 「医療・介護関連肺炎(NHCAP)」とは―抗菌薬選択と患者ケアにおける注意点― Invited

    進藤有一郎、長谷川好規

    エキスパートナース   Vol. 28   page: 18-23   2012

     More details

    Authorship:Lead author   Language:Japanese  

  57. NHCAPの実態 Invited

    進藤有一郎、長谷川好規

    メディカル朝日   Vol. 40   page: 18–19   2011

     More details

    Authorship:Lead author   Language:Japanese  

  58. 新たな肺炎の概念―「医療ケア関連肺炎」の臨床 Invited

    進藤有一郎、長谷川好規

    分子呼吸器病   Vol. 15   page: 58–65   2011

     More details

    Authorship:Lead author   Language:Japanese  

  59. 新たな肺炎の概念―HCAPの位置付け治療戦略を探る―日本と米国の視点から-日本版ガイドライン(NHCAP)はどうあるべきか Invited

    河野茂、Marin H. Kollef、朝野和典、門田淳一、進藤有一郎

    化学療法の領域   Vol. 27   page: 126–135   2011

     More details

    Language:Japanese  

  60. 呼吸器感染症ガイドラインの評価と今後の課題:医療ケア関連肺炎 Invited

    進藤有一郎、長谷川好規

    化学療法の領域   Vol. 27   page: 117–124   2011

     More details

    Authorship:Lead author   Language:Japanese  

  61. 変貌する肺炎の臨床への対策 Invited

    河野茂、門田淳一、進藤有一郎、朝野和典

    呼吸   Vol. 30   page: 427–434   2011

     More details

    Language:Japanese  

  62. NHCAPの特徴は?:重症度と耐性菌のリスクについて Invited

    進藤有一郎、長谷川好規

    医薬ジャーナル   Vol. 47   page: 113-117   2011

     More details

    Authorship:Lead author   Language:Japanese  

  63. Second line weekly paclitaxel in resistant or relapsed non-small cell lung cancer treated with docetaxel and carboplatin: a multi-center phase II study Reviewed

    Ichikawa M, Suzuki R, Kataoka K, Noda Y, Shindoh J, Matsumoto S, Tanikawa Y, Suzuki K, Baba K, Shindo Y, Kondo M, Imaizumi K, Kume H, Hasegawa Y, Takagi K, Taniguchi H

    Lung Cancer   Vol. 69   page: 319-322   2010

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  64. 医療ケア関連肺炎(Healthcare-associated pneumonia: HCAP):新たな肺炎の概念 Invited

    進藤有一郎、長谷川好規

    呼吸器内科   Vol. 17   page: 62–70   2010

     More details

    Authorship:Lead author   Language:Japanese  

  65. 医療ケア関連肺炎 (Healthcare-associated pneumonia: HCAP) はCAPやHAPとは対応が異なる Invited

    進藤有一郎、長谷川好規

    モダンフィジシャン   Vol. 30   page: 608–614   2010

     More details

    Authorship:Lead author   Language:Japanese  

  66. 医療ケア関連肺炎(Health-Care-Associated Pneumonia: HCAP)の対応と治療戦略 Invited

    進藤有一郎

    Infection File   Vol. 29   page: 9   2010

     More details

    Authorship:Lead author   Language:Japanese  

  67. 医療ケア関連肺炎(Health-care-associated pneumonia: HCAP):新たな肺炎の概念 Invited

    進藤有一郎、長谷川好規

    Geriatric Medicine   Vol. 10   page: 1307–1316   2010

     More details

    Authorship:Lead author   Language:Japanese  

  68. 肺炎の分類 CAP(市中肺炎)、HCAP(医療ケア関連肺炎)、HAP(院内肺炎) Invited

    進藤有一郎、長谷川好規

    綜合臨床   Vol. 59   page: 2034–2040   2010

     More details

    Authorship:Lead author   Language:Japanese  

  69. ユーザーメード肺炎データベースと基幹システムとの連携:診療支援・教育・多施設共同前向き研究ツールへの応用と課題

    進藤有一郎、長谷川好規、八木哲也、高橋正樹、吉田茂

    医療情報学   Vol. 30   page: S591–594   2010

     More details

    Authorship:Lead author   Language:Japanese   Publishing type:Research paper (scientific journal)  

  70. Health-Care-Associated Pneumonia Is Primarily Due to Aspiration Pneumonia: Response Invited Reviewed

    Shindo Y, Imaizumi K, Hasegawa Y

    Chest   Vol. 136   page: 1703   2009

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  71. HCAPの病態, そして診断と治療-日本の現状を語る- Invited

    三鴨廣繁、栁原克紀、石田直、進藤有一郎

    Mebio   Vol. 26   page: 119–125   2009

     More details

    Language:Japanese  

  72. Health-Care-Associated-Pneumonia(HCAP)の治療戦略について-欧米の現状と日本の今後-日本版ガイドライン作成に向けての提言 Invited

    河野茂、Lee E. Morrow、三鴨廣繁、石田直、関雅文、進藤有一郎

    化学療法の領域   Vol. 25   page: 108–121   2009

     More details

    Language:Japanese  

  73. 院内肺炎の現状と今後の治療戦略 Invited

    渡辺彰、三鴨廣繁、寺本信嗣、関雅文、進藤有一郎

    Medical Tribune   Vol. 41   page: 78–81   2008

     More details

    Language:Japanese  

  74. フッ素樹脂(テフロン)加工鍋の空焚きによりポリマーヒューム熱(PFF)と間質性肺炎をきたした1例 Reviewed

    孫政実, 丸山英一, 進藤有一郎, 菅沼伸一, 佐藤慎二, 小川雅弘

    中毒研究   Vol. 19   page: 279–282   2006

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

  75. 禁煙にて軽快を示した肋骨原発Langerhans cell histiocytosisの1例 Reviewed

    野間聖, 西山理, 岩木舞, 阪本考司, 麻生裕紀, 進藤有一郎, 加藤景介, 木村智樹, 近藤康博, 谷口博之

    日本呼吸器学会雑誌   Vol. 44   page: 43–47   2006

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

  76. Covered expandable metalic Stent placement for hemostasis of colonic bleeding caused by invasion of gallbladder carcinoma Reviewed

    Hasegawa N, Kato K, Morita K, Kuroiwa M, Shinkai M, Hayashi T, Kamioka T, Otagiri H, Shindo Y, Goto H

    Endoscopy   Vol. 35   page: 178–180   2003

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  77. 気道内にポリープを呈した子宮肉腫肺転移の1例 Reviewed

    矢野誠, 谷口博之, 近藤康博, 木村智樹, 西山理, 清水淳一, 長谷川隆一, 進藤有一郎, 阪本考司

    気管支学   Vol. 25   page: 482–483   2003

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

  78. 超低体温循環停止下両側肺動脈血せん内膜摘除術が著効したOver-Systemic肺高血圧を呈する慢性肺動脈血せん塞せん症の1例

    江田匡仁, 進藤有一郎, 矢野隆, 市原利彦, 上田裕一, 安藤太三

    呼吸と循環   Vol. 51   page: 401–406   2003

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

▼display all

Books 14

  1. Macrolide therapy for patients with pneumonia: a triple-edged sword. In: Aliberti S, Chalmers JD, Pletz M, eds. Anti-infectives and the Lung (ERS Monograph)

    Shindo Y, Hasegawa Y( Role: Joint author)

    European Respiratory Society  2017 

     More details

    Language:English Book type:Scholarly book

  2. Health-Care-Associated Pneumonia among Hospitalized Patients. In: Esquinas A, ed. Applied Technologies in Pulmonary Medicine

    Shindo Y, Hasegawa Y( Role: Joint author)

    Karger Medical and Scientific Publishers  2011  ( ISBN:978-3-8055-9585-8

     More details

    Language:English

  3. 新 呼吸器専門医テキスト 改訂第2版. 各論Ⅰ 気道・肺疾患 E. 肺膿瘍

    進藤有一郎.( Role: Joint author)

    南江堂  2020 

     More details

    Responsible for pages:324-326   Language:Japanese Book type:Scholarly book

  4. 呼吸器疾患診断治療アプローチ 呼吸器感染症 第4章 特殊病態下(免疫抑制患者)の呼吸器感染症 医療・介護に関連した呼吸器感染症

    進藤有一郎, 長谷川好規( Role: Joint author)

    中山書店  2017 

     More details

    Language:Japanese Book type:Scholarly book

  5. 呼吸器病レジデントマニュアル (第5版). 第3章 主な呼吸器疾患の診断と治療 A. 肺感染症 2. 市中肺炎

    進藤有一郎( Role: Sole author)

    医学書院  2015 

     More details

    Language:Japanese Book type:Scholarly book

  6. 別冊「医学のあゆみ」 呼吸器疾患 state of arts Ver.6 第4章 主要疾患―病態・診断・治療 15. 医療・介護関連肺炎(NHCAP)

    進藤有一郎、長谷川好規( Role: Joint author)

    医歯薬出版株式会社  2013 

     More details

    Language:Japanese

  7. 呼吸器疾患 最新の治療 2013―2015 第XV章 呼吸器疾患の患者指導 4.誤嚥性肺炎防止のための患者指導

    進藤有一郎、長谷川好規( Role: Joint author)

    南江堂  2013 

     More details

    Language:Japanese

  8. 抗菌薬の選択と使い方 呼吸器内科領域

    進藤有一郎、長谷川好規( Role: Joint author)

    医薬ジャーナル社  2012 

     More details

    Language:Japanese

  9. ガイドラインサポートハンドブック 呼吸器感染症 第IV章 欧米ガイドラインとの比較 3.クライテリア

    進藤有一郎, 長谷川好規, 他( Role: Joint author)

    医薬ジャーナル社  2011.6  ( ISBN:978-4-7532-2499-9

     More details

    Language:Japanese

  10. 肺炎ガイドライン活用のための抗菌薬のかしこい使い方 第I章B 肺炎ガイドラインを使いこなすポイント 8.中等症例での抗菌薬の使い方のコツは?

    進藤有一郎, 長谷川好規, 他( Role: Joint author)

    南江堂  2009.10  ( ISBN:978-4-524-26012-6

     More details

    Language:Japanese

  11. 最新抗菌薬療法マニュアル 第II章 疾患各論 4.医療ケア関連肺炎;何を選んでどう使うか?

    進藤有一郎, 長谷川好規, 他( Role: Joint author)

    新興医学出版社  2009.9  ( ISBN:978-4-88002-688-6

     More details

    Language:Japanese

  12. Advances in Aging and Health Research 2017. 高齢者の感染症とその対策. 第3章 各論1 高齢者の各種感染症 高齢者の肺炎.

    進藤有一郎、長谷川好規.( Role: Joint author)

    公益財団法人 長寿科学振興財団  2018 

     More details

    Responsible for pages:41-49   Language:Japanese

  13. 新 呼吸器専門医テキスト. 各論Ⅰ 気道・肺疾患 E. 肺化膿症.

    進藤有一郎.( Role: Joint author)

    南江堂  2017 

     More details

    Responsible for pages:283-284   Language:Japanese Book type:Scholarly book

  14. 新 呼吸器専門医テキスト. 各論Ⅰ 気道・肺疾患 E. 肺化膿症

    進藤有一郎( Role: Sole author)

    南江堂  2015 

     More details

    Language:Japanese Book type:Scholarly book

▼display all

Presentations 43

  1. The role of lymphocytopenia in patients with nosocomial pneumonia & future directions of research on host immunity and adjunctive therapy for severe pneumonia. Invited International conference

    Shindo Y.

    The International Respiratory Infections 2019 Conference  2019.5  The International Respiratory Infection Society

     More details

    Event date: 2019.5

    Language:English   Presentation type:Oral presentation (invited, special)  

    Venue:Dallas   Country:United States  

  2. Immunotherapeutic strategies for sepsis and pneumonia Invited International conference

    Shindo Y

    The International Respiratory Infections Conference 2017 

     More details

    Event date: 2017.5

    Language:English   Presentation type:Oral presentation (general)  

    Venue:Washington, D.C., USA   Country:United States  

  3. An extra-pulmonary etiology of non-resolving pneumonia Invited International conference

    Shindo Y

    European Respiratory Society International Congress 2016 

     More details

    Event date: 2016.9

    Language:English   Presentation type:Oral presentation (invited, special)  

    Venue:London, UK   Country:United Kingdom  

  4. Healthcare-associated pneumonia among hospitalized patients in a Japanese community hospital International conference

    Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Hashimoto N, Imaizumi K, Sato T, Hasegawa Y

    ATS 2009 International Conference 

     More details

    Event date: 2009.5

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  5. Interleukin 7 immunotherapy improves survival in sepsis followed by secondary Pseudomonas aeruginosa pneumonia International conference

    Shindo Y, Fuchs AG, Davis CG, Unsinger J, Eitas T, Burnham C, Green JM, Bochicchio GV, Hotchkiss RS

    American Thoracic Society 2016 International Conference 

     More details

    Event date: 2016.5

    Language:English   Presentation type:Poster presentation  

    Venue:San Francisco   Country:Japan  

  6. Risk Factors for 30-Day Mortality in Patients with Pneumonia Who Receive Appropriate Initial Antibiotics: Who are the Candidates for Adjunctive Therapy? International conference

    Shindo Y

    CAPO Research Symposium 2015 

     More details

    Event date: 2015.5

    Language:English   Presentation type:Oral presentation (general)  

    Country:Japan  

  7. Risk Factors for Severe Adverse Outcomes in Patients with Hospital-Acquired Pneumonia International conference

    Sano M, Shindo Y, Okumura J, Sakakibara T, Matsuda T, Yagi T, Matsui K, Takahashi K, Matsui S, Hasegawa Y

    American Thoracic Society 2017 International Conference 

     More details

    Event date: 2017.5

    Language:English   Presentation type:Poster presentation  

    Venue:Washington, D.C., USA   Country:United States  

  8. 大規模臨床研究結果からみえてくる肺炎診療の課題と治療戦略への提言 Invited

    進藤有一郎

    第56回日本呼吸器学会学術講演会 

     More details

    Event date: 2016.4

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Venue:京都   Country:Japan  

  9. Risk Factors of Resistant Pathogens for Beta-lactam plus Macrolide, or Fluoroquinolone in Hospitalized Patients with CAP and HCAP: A Multicenter Prospective Observational Study among Patients with CAP, HCAP, and HAP in Japan (CJLSG 0911) International conference

    Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Yagi T, Sugino Y, Shindoh J, Ogasawara T, Nomura F, Saka H, Yamamoto M, Taniguchi H, Suzuki R, Saito H, Kawamura T, and Hasegawa Y

    CHEST 2012 

     More details

    Event date: 2012.10

    Language:English   Presentation type:Oral presentation (general)  

    Country:United States  

  10. What do physicians need for the guidelines for Nursing and Health-Care-Associated Pneumonia?

    Yuichiro Shindo

    The 86th Annual Meeting of the Japanese Association for Infectious Diseases 

     More details

    Event date: 2012.4

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Country:Japan  

  11. Clinical and Molecular Characteristics of Pneumocystis Pneumonia in 52 Non-HIV-Infected Patients in 2 Japanese University Hospitals International conference

    Matsumura Y, Shindo Y, Shirano M, Matsushima A, Nagao M, Ito Y, Takakura S, Iinuma Y, Ichiyama S

    47th Annual Meeting of IDSA 

     More details

    Event date: 2009.10

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  12. COVID-19診療における現場の疑問点を考察する ―呼吸器学会FAQ広場に寄せられた質問を中心に― 抗ウイルス剤 Invited

    進藤有一郎

    第61回日本呼吸器学会学術講演会  2021.4.23  日本呼吸器学会

     More details

    Event date: 2021.4

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    Venue:東京  

  13. Common diseaseを適切に管理するには―限られた資源の有効活用― Invited

    進藤有一郎

    第60回日本呼吸器学会学術講演会  2020.9  日本呼吸器学会

     More details

    Event date: 2020.9

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Venue:神戸   Country:Japan  

  14. 透析患者における感染症の特徴と対策 呼吸器感染症の実態と対策 Invited

    進藤有一郎

    第94回日本感染症学会総会  2020.8  日本感染症学会

     More details

    Event date: 2020.8

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Venue:東京   Country:Japan  

  15. 生物学的製剤と呼吸器感染症 細菌性肺炎 Invited

    進藤有一郎

    第94回日本感染症学会総会  2020.8  日本感染症学会

     More details

    Event date: 2020.8

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Venue:東京   Country:Japan  

  16. A New Scoring System for Predicting Adverse Events in Hospitalized Patients with Community-Onset Pneumonia

    Sakakibara T., Shindo Y., Takahashi K., Kobayashi D., Okumura J., Sano M., Murakami Y., Thabet N., Kobayashi H., Yagi T., Matsui S., Saka H., Hasegawa Y.

    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE  2019.5  American Thoracic Society

     More details

    Event date: 2019.5

    Language:English   Presentation type:Oral presentation (general)  

    Venue:Dallas   Country:United States  

  17. Severe and Prolonged Lymphopenia Are Associated with Poor Outcome in Patients with Postoperative Pneumonia

    Murakami Y., Shindo Y., Sano M., Okumura J., Sakakibara T., Kobayashi H., Thabet N., Yagi T., Hasegawa Y.

    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE  2019.5  American Thoracic Society

     More details

    Event date: 2019.5

    Language:English   Presentation type:Oral presentation (general)  

    Venue:Dallas   Country:United States  

  18. Risk factors for drug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia International conference

    Sano M, Shindo Y, Okumura J, Sakakibara T, Matsuda T, Yagi T, and Hasegawa Y

    European Respiratory Society International Congress 2017  2017.9  European Respiratory Society

     More details

    Event date: 2017.9

    Language:English   Presentation type:Oral presentation (general)  

    Venue:Milan   Country:Italy  

  19. Risk Factors For Severe Adverse Outcomes In Patients With Hospital-Acquired Pneumonia International conference

    Sano M., Shindo Y., Okumura J., Sakakibara T., Matsuda T., Yagi T., Matsui K., Takahashi K., Matsui S., Hasegawa Y.

    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE  2017.5  American Thoracic Society

     More details

    Event date: 2017.5

    Language:English   Presentation type:Oral presentation (general)  

    Venue:Washington, D.C.   Country:United States  

  20. Implication of β-lactam plus macrolide combination therapy on mortality in patients with community-onset pneumonia at low risk for drug-resistant pathogens. International conference

    Okumura J, Shindo Y, Sano M, Sakakibara T, Matsuda T, Takahashi K, Saka H, Matsui S, and Hasegawa Y.

    Asian Pacific Society of Respirology 2017 Congress  2017  Asian Pacific Society of Respirology

     More details

    Event date: 2017

    Language:English   Presentation type:Oral presentation (general)  

    Venue:Sydney   Country:Australia  

  21. Mortality Risks in Patients with Pneumonia Who Received Appropriate Initial Antibiotics International conference

    Shindo Y, Kobayashi D, Ito R, Ando M, Ichikawa M, Yagi T, Tanikawa Y, Sugino Y, Shindoh J, Ogasawara T, Nomura F, Saka H, Yamamoto M, Taniguchi H, Suzuki R, Saito H, Kawamura T, and Hasegawa Y

    American Thoracic Society 

     More details

    Event date: 2014.5

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  22. Coordination of a user-made database of pneumonia and EMR: A potentially useful tool for medical support, education, and multicenter prospective study

    Yuichiro Shindo, Daisuke Kobayashi, Ryota Ito, Yoshinori Hasegawa, Mitsutaka Iguchi, Yuka Tomita, Testuya Yagi, Masaki Takahashi, Shigeru Yoshida

    The 86th Annual Meeting of the Japanese Association for Infectious Diseases 

     More details

    Event date: 2012.4

    Language:Japanese   Presentation type:Oral presentation (general)  

    Country:Japan  

  23. Future Perspectives on the Guidelines for Patients with Community-Acquired Pneumonia: A Proposals for the Revisions

    Yuichiro Shindo

    The 52nd Annual Meeting of the Japanese Respiratory Society 

     More details

    Event date: 2012.4

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Country:Japan  

  24. Evidence of Patients with Health-Care-Associated Pneumonia in Japan: Controversies Surrounding the HCAP Concept International conference

    Yuichiro Shindo

    The 52nd Annual Meeting of the Japanese Respiratory Society 

     More details

    Event date: 2012.4

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Country:Japan  

  25. Guidelines for Nursing and Health-Care-Associated Pneumonia in Japan: Controversies Surrounding the NHCAP Concept International conference

    Yuichiro Shindo

    The 52nd Annual Meeting of the Japanese Respiratory Society 

     More details

    Event date: 2012.4

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Country:Japan  

  26. Prospective Analysis of Efficacy and Safety of Individualized Administration of Midazolam for Sedation During Bronchoscopy International conference

    2. Imaizumi K, Hashimoto I, Shindo Y, Imai N, Ogawa T, Morise M, Ito S, Hashimoto N, Sato M, Kondo M, and Hasegawa Y

    CHEST 2011 

     More details

    Event date: 2011.10

    Language:English   Presentation type:Poster presentation  

    Country:Japan  

  27. 肺炎治療に必要な新概念「医療・介護関連肺炎」~「誤嚥」患者に対する一味違った抗菌薬の選び方~

    進藤有一郎

    第52回日本神経学会総会 

     More details

    Event date: 2011.5

    Language:English   Presentation type:Symposium, workshop panel (nominated)  

    Venue:名古屋   Country:Japan  

  28. 日本のNHCAPの実態(2)~新たな肺炎カテゴリーの現状と今後の課題~

    進藤有一郎

    第51回日本呼吸器学会学術講演会 

     More details

    Event date: 2011.4

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Venue:東京   Country:Japan  

  29. ユーザーメード肺炎データベースと基幹システムとの連携:診療支援・教育・多施設共同前向き研究ツールへの応用と課題

    進藤有一郎、長谷川好規、八木哲也、高橋正樹、吉田茂

    第30回医療情報学連合大会 

     More details

    Event date: 2010.11

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:浜松   Country:Japan  

  30. 医療ケア関連肺炎の診断と治療 ~新たな肺炎の治療概念~

    進藤有一郎.

    第52回日本老年医学会学術集会 

     More details

    Event date: 2010.6

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    Venue:神戸   Country:Japan  

  31. 本邦におけるHCAPの実態-CAP, HAPガイドラインによる分類からの検証-

    進藤有一郎

    第58回日本化学療法学会総会 

     More details

    Event date: 2010.6

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Venue:長崎   Country:Japan  

  32. 医療ケア関連肺炎の現状と今後の課題

    進藤有一郎

    第58回日本化学療法学会総会 

     More details

    Event date: 2010.6

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Venue:長崎   Country:Japan  

  33. 呼吸器内科専門医育成に望むこと―若手医師の立場から―

    進藤有一郎

    第50回日本呼吸器学会学術講演会 

     More details

    Event date: 2010.4

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Venue:京都   Country:Japan  

  34. 医療ケア関連肺炎の診断と治療-新たな肺炎の概念-

    進藤有一郎

    第25回日本環境感染学会総会 

     More details

    Event date: 2010.2

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    Venue:東京   Country:Japan  

  35. 医療ケア関連肺炎(HCAP)とJRS院内肺炎ガイドライン:HCAPの治療戦略の在り方はどうあるべきか?

    進藤有一郎、佐藤慎二、丸山英一、大橋能理、小川雅弘、伊藤理、橋本直純、佐藤光夫、近藤征史、今泉和良、長谷川好規

    第49回日本呼吸器学会学術講演会 

     More details

    Event date: 2009.6

    Language:Japanese   Presentation type:Poster presentation  

    Venue:東京   Country:Japan  

  36. 市中病院におけるHealth care-associated pneumonia (HCAP): 市中肺炎(CAP)との比較研究

    進藤有一郎、佐藤慎二、丸山英一、大橋能理、小川雅弘、伊藤理、近藤征史、橋本直純、今泉和良、佐藤俊哉、長谷川好規

    第48回日本呼吸器学会学術講演会 

     More details

    Event date: 2008.6

    Language:Japanese   Presentation type:Symposium, workshop panel (public)  

    Venue:神戸   Country:Japan  

  37. 市中病院におけるHealth care-associated pneumonia (HCAP): 市中肺炎(CAP)との比較研究

    進藤有一郎、佐藤慎二、丸山英一、大橋能理、小川雅弘、伊藤理、近藤征史、橋本直純、今泉和良、佐藤俊哉、長谷川好規

    第82回日本感染症学会総会 

     More details

    Event date: 2008.4

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:松江   Country:Japan  

  38. 当院での市中肺炎入院症例の検討~スウィッチ療法を含んだクリニカル・パス使用効果について~

    進藤有一郎、佐藤慎二、丸山英一、大橋能理、小川雅弘

    第47回日本呼吸器学会学術講演会 

     More details

    Event date: 2007.5

    Language:Japanese   Presentation type:Poster presentation  

    Venue:東京   Country:Japan  

  39. TSガイドライン(2001年)による市中肺炎入院症例の検討

    進藤有一郎, 谷口博之, 近藤康博, 木村智樹, 西山理, 清水淳市

    第44回日本呼吸器学会学術講演会 

     More details

    Event date: 2006.3

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:東京   Country:Japan  

  40. 当院における在宅NPPV療法施行症例の検討

    進藤有一郎, 谷口博之, 近藤康博, 西山理, 清水淳市, 矢野誠, 阪本考司, 麻生裕紀, 長谷川隆一

    第25回日本呼吸管理学会学術集会 

     More details

    Event date: 2003.8

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:幕張   Country:Japan  

  41. 喘息急性増悪に対するmontelukastの追加効果に関する検討

    進藤有一郎, 谷口博之, 近藤康博, 西山理

    第15回日本アレルギー学会春季臨床大会 

     More details

    Event date: 2003.5

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:横浜   Country:Japan  

  42. 頻回に血球貪食症候群を呈した成人発症スティル病の一例

    進藤有一郎, 石川英昭, 中村智信, 北川渡, 林宏樹, 稲熊大城, 近藤康博, 若尾孝明, 公文進一

    第46回日本リウマチ学会総会 

     More details

    Event date: 2002.4

    Language:Japanese   Presentation type:Poster presentation  

    Venue:神戸   Country:Japan  

  43. 術前over systemicを呈した慢性血栓塞栓性肺高血圧症に対する肺動脈血栓内膜摘除術〜術後管理を中心に〜

    進藤有一郎, 市原利彦, 川瀬正樹, 上田裕一

    第29回日本集中治療医学会総会 

     More details

    Event date: 2002.2

    Language:Japanese   Presentation type:Poster presentation  

    Venue:岡山   Country:Japan  

▼display all

KAKENHI (Grants-in-Aid for Scientific Research) 4

  1. 軽度呼吸不全を呈するCOVID-19肺炎患者に対するファビピラビル/ステロイド併用療法の多施設共同第II相試験

    Grant number:20fk0108256h0001  2020.7 - 2021.3

    日本医療研究開発機構(AMED) 

  2. 重症呼吸器感染症の免疫動態解明とIL-7を含めた新規免疫療法ストラテジーの構築

    Grant number:20K08517  2020.4 - 2023.3

    進藤 有一郎

      More details

    Authorship:Principal investigator 

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

    研究代表者の先行研究で国際的に初めて明らかにした適切な抗菌治療を受けた肺炎患者における死亡リスク因子は自然・獲得免疫機能低下との関連が報告されており、免疫賦活療法の適応となる患者の存在が示唆される。しかし、免疫賦活療法として具体的に何を?いつ?使えばよいかについては答えが現在ない。
    本研究は、主に重症肺炎患者検体を用いて予後良好/不良群の免疫状態とその経時的変化の違いを明らかにすることで、IL-7を基軸とした免疫賦活療法の投与対象候補者と投与タイミングを探索するとともに、確立してきた動物モデルを用いて有効性の機序をより明確化し将来の臨床試験への基盤をつくることを目的として行われる。

  3. Development of novel immunotherapy including IL-7 for severe respiratory tract infections

    Grant number:17K09610  2017.4 - 2020.3

    Shindo Yuichiro

      More details

    Authorship:Principal investigator 

    Grant amount:\4550000 ( Direct Cost: \3500000 、 Indirect Cost:\1050000 )

    We developed a two-hit mouse model of sepsis and secondary Pseudomonas pneumonia. The results showed that IL-7 administration after sepsis onset improved the survival of the two-hit model (JLB 2017). Anti-PD-L1 peptide was also effective for improving the survival of septic mouse model (JSR 2017).
    In patients with severe community-acquired pneumonia and those with post-operative pneumonia, we reported that time courses of absolute counts of lymphocytes and neutrophils were different between survivors and non-survivors in both pneumonia groups (ATS 2019). From these results, we made presentations on the perspectives on possible immunotherapeutic strategies in patients with severe respiratory tract infections (IRIC 2017, IRIC 2019).

  4. Cross-talk between the kidneys and the lungs

    Grant number:15K09282  2015.4 - 2018.3

    Yuzawa Yukio

      More details

    Authorship:Coinvestigator(s) 

    Organ crosstalk is known to occur in the presence of kidney injury, with the injury spreading to distal organs, including the heart. However, little knowledge exists on the crosstalk linking the kidneys and lungs. Thus, we aimed to clarify the kidney-lung crosstalk by conducting a prospective observational study on the onset and prognosis of acute kidney injury (AKI) in a cohort of patients hospitalized for pneumonia. A new severity score that takes AKI into account would allow for an easy and accurate estimation of the mortality risk during treatment of pneumonia, which causes more than 110,000 deaths in Japan per year, accounting for the third highest number of deaths after malignant neoplasms and heart disease. This study does not only verify the crosstalk between the kidneys and the lungs but also recommends the importance of future medical treatment based on organ crosstalk rather than being constrained to treatment for single organs.

 

Teaching Experience (On-campus) 6

  1. 基盤医学特論

    2012

  2. 臨床実習 ポリクリⅠ

    2012

  3. 胸部レントゲン写真の読影

    2012

  4. 呼吸器感染症1

    2012

  5. 臨床実習 ポリクリⅠ

    2011

  6. 胸部レントゲン写真の読影

    2011

▼display all